The effects on the inhibition potencies of monoamine oxidase isoforms A (MAO-A) and B (MAO-B) depending upon changes in the physicochemical properties (size, shape, H-bonding, lipophilicity, etc.) of substituents at the C4 position of 2H-chromen-2-one derivatives were extensively investigated, and the results significantly added to our knowledge on this class of MAO inhibitors. All the 67 examined compounds showed high MAO-B selectivity, some of them achieving potency in the low nanomolar range. In particular, the 7-metachlorobenzyloxy-4-oxyacetamido-2H-chromen-2-one (entry 62) showed single digit nanomolar MAO-B potency (IC50 \ubc 3.1 nM) and high selectivity over the MAO-A isoform (selectivity ratio \ubc 7244). The great variety of the in...
The general blueprint for the design of monoamine oxidase-B (MAO-B) inhibitors has been based on two...
A previous study has shown that a series of C6-benzyloxy substituted chromones exhibit high binding ...
Monoamine oxidase B (MAO B) catalyzes the oxidative deamination of aryalkylamines neurotransmitters ...
Inhibition data on rat monoamine oxidase B isoform of a large number of 7-metahalobenzyloxy-2Hchrome...
The discovery of new chemical entities endowed with potent, selective, and reversible monoamine oxid...
Monoamine oxidase B (MAO B) catalyzes the oxidative deamination of aryalkylamines neurotransmitters ...
Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depre...
In an effort to discover novel selective monoamine oxidase (MAO) B inhibitors with favorable physico...
Based on a previous report that substituted 2-acetylphenols may be promising leads for the design of...
Monoamine oxidases (MAOs) are mitochondrial FAD-containing enzymes that catalyze the oxidative deami...
A large plethora of drugs and promising lead compounds contain halogens in their structures. The int...
Aim and Objective: Specific inhibitors of monoamine oxidase (MAO)-B are considered useful therapeuti...
International audienceMonoamine oxidase B (MAO-B) is a validated drug target for Parkinson's disease...
The use of selective inhibitors of monoamine oxidase A (MAO-A) and B (MAO-B) holds a therapeutic rel...
Purpose Monoamine oxidase (MAO) inhibitors are considered to be useful therapeutic agents and isofor...
The general blueprint for the design of monoamine oxidase-B (MAO-B) inhibitors has been based on two...
A previous study has shown that a series of C6-benzyloxy substituted chromones exhibit high binding ...
Monoamine oxidase B (MAO B) catalyzes the oxidative deamination of aryalkylamines neurotransmitters ...
Inhibition data on rat monoamine oxidase B isoform of a large number of 7-metahalobenzyloxy-2Hchrome...
The discovery of new chemical entities endowed with potent, selective, and reversible monoamine oxid...
Monoamine oxidase B (MAO B) catalyzes the oxidative deamination of aryalkylamines neurotransmitters ...
Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depre...
In an effort to discover novel selective monoamine oxidase (MAO) B inhibitors with favorable physico...
Based on a previous report that substituted 2-acetylphenols may be promising leads for the design of...
Monoamine oxidases (MAOs) are mitochondrial FAD-containing enzymes that catalyze the oxidative deami...
A large plethora of drugs and promising lead compounds contain halogens in their structures. The int...
Aim and Objective: Specific inhibitors of monoamine oxidase (MAO)-B are considered useful therapeuti...
International audienceMonoamine oxidase B (MAO-B) is a validated drug target for Parkinson's disease...
The use of selective inhibitors of monoamine oxidase A (MAO-A) and B (MAO-B) holds a therapeutic rel...
Purpose Monoamine oxidase (MAO) inhibitors are considered to be useful therapeutic agents and isofor...
The general blueprint for the design of monoamine oxidase-B (MAO-B) inhibitors has been based on two...
A previous study has shown that a series of C6-benzyloxy substituted chromones exhibit high binding ...
Monoamine oxidase B (MAO B) catalyzes the oxidative deamination of aryalkylamines neurotransmitters ...